"The price of greatness is responsibility." Sir Winston Churchill


Search the IBPA



Top Menu

Menu Sidebar

IBPA Issues
About IBPA
IBPA Constitution
FAQ-s
IBPA Events
Individual Membership
Institutional Membership
IBPA Forums / Groups
Cooperation with IBPA
Links

Publications
IBPA Careers Newsletter
Past Issues
Industry Publications
Promote Yourself within the Industry
Submit Your Article

Career Center: Employers
Job Posting
Free Resume Database
Volunteers Database

Career Center: Job Seekers
Now Hiring
Submit Resume
Career Training
Nurses Careers in Biopharm
Scholarship Programs
Internship Programs
Resume Editing & Interview Coaching
Volunteer for the Industry
Download IBPA Career Info Brochure

Industry Directories and Listings
Pharmaceutical Companies
Contract Research Organizations
Professional Associations
Recruiters and Staffing Agencies
Clinical Research Centers
Consulting Companies
Education & Training Institutions
Jobs and Resume Searching Directories
Research and Development Companies
Industry Service Providers
List Your Company

Investor's Center
Offers
Calls

Contact IBPA
USAChapter
Canadian Chapter
European Chapter
Asian Chapter

Start Your Career in Biotech with IBPA Scholarship Programs
Untitled Document



Subscribe to our "Careers in the Biopharmaceutical Industry" newsletter:

Name*:

Email*:

City:

Country:

Phone:

To unsubscribe, click here

 

 

New Freedom Commission on Mental Health

From Wikipedia, the free encyclopedia.

 
This article may not conform to the neutral point of view policy.
A Wikipedian has nominated this article to be checked for its neutrality. Discussion of this nomination can be found on the talk page.
 

President George W. Bush established the President’s New Freedom Commission on Mental Health in April 2002 as part of his commitment to eliminate inequality for Americans with disabilities. The President directed the Commission to identify policies that could be implemented by Federal, State and local governments to maximize the utility of existing resources, improve coordination of treatments and services, and promote successful community integration for adults with a serious mental illness and children with a serious emotional disturbance.[1] Opponents of the plan claim that its objectives are to foster mind control of American citizens and increase the profits of pharmaceutical companies. A broad-based coalition of mental health consumers, families, providers, and adovcates has enthusiastically supported the Commission process and recommendations, using the Commission's findings as a launching point for recommending widespread reform of the nation's mental health system. [2]

Critics, concerned by what they see as the pharmaceutical industry's use of front organizations[3] and compromise of scientific integrity under color of authority,[4] look askance at the irony of the commission's 'freedom' descriptor, contending the commission is yet another example of the excesses of drug industry marketing[5][6] and that the effects of its recommendations will simply foster drug use rather than prevention and alternative treatment modalities. Opponents of the plan see little in the way of potential benefits from the plan, except increased profits for pharmaceutical companies, and have grave concerns about the potential for unnecessarily causing neurological damage and contributing to increased substance abuse.

Contents

[hide]

[edit]

 

Commission reports

On July 22, 2003, the President's hand picked commission returned a report recommending a nationwide screening program based on the Texas Medication Algorithm Project (TMAP), which was created in 1995 while President Bush was governor of Texas, beginning as an alliance of individuals from the University of Texas, the pharmaceutical industry, and the mental health and corrections systems of Texas. The commission reported that "despite their prevalence, mental disorders often go undiagnosed," so it recommended comprehensive mental health screening for "consumers of all ages," including preschool children, because "each year, young children are expelled from preschools and childcare facilities for severely disruptive behaviors and emotional disorders."

The report of the commission was accepted enthusiastically by certain consumer, provider and other interest groups in mental health. The most enthusiatic response has centered around the commission's emphasis on recovery from mental illness, its call for consumer and family-centered care, and the recommendation that states develop a more comprehensive approach to mental health.

Opponents of the plan have questioned the motives of the commission largely from a civil liberties perspective, asserting the intitiative campaign is little more than a thinly veiled proxy for the pharmaceutical industry, which, in its pursuit of profits, is too eager to foster psychotropic medication interventions, often coercively.

[edit]

 

Opposition brewing

However, the plan by President Bush to screen all Americans for mental health problems is being opposed by a coalition of advocacy groups, who say the plan was cooked up by the pharmaceutical industry. A coalition of over 100 advocacy organizations, united under the banner of MindFreedom International in representing the psychiatric survivors movement, has been galvanized by their strong opposition to the New Freedom Commission. Using celebrity to advance their opposition, the MindFreedom coalition has again enlisted the support of long time member and Gesundheit Institute founder Patch Adams, an alternative medicine practitioner made famous by the movie that bears his name. Since 1992, Adams has supported MindFreedom campaigns, and in August, 2004, he kicked off the campaign against the New Freedom Commission by volunteering to screen President Bush himself. "He needs a lot of help. I'll see him for free," said Adams.

Through the guise of TMAP, critics contend, the drug industry has methodically influenced the decision making of elected and appointed public officials to gain access to citizens in prisons and State mental health hospitals. The person primarily responsible for bringing these issues to the public's attention is Allen Jones, a former investigator in the Commonwealth of Pennsylvania Office of Inspector General (OIG), Bureau of Special Investigations.

Jones wrote a lengthy report in which he stated that, behind the recommendations of the New Freedom Commission, was the "political/pharmaceutical alliance." It was this alliance, according to Jones, which developed the Texas project, specifically to promote the use of newer, more expensive antipsychotics and antidepressants. He further claimed this alliance was "poised to consolidate the TMAP effort into a comprehensive national policy to treat mental illness with expensive, patented medications of questionable benefit and deadly side effects, and to force private insurers to pick up more of the tab."

A bill, 'The Parental Consent Act of 2005', or HR 181, has been introduced in the US House of Representatives by Dr. Ron Paul, MD, a Republican from Texas. The proposal forbids federal funds from being used for any mental health screening of students without the express, written, voluntary, informed consent of parents.

Opponents of the plan suggest it fosters the use of progressively more stringent and coercive use of chemical interventions, championed by Sally Satel and other pharmaceutical industry backers, rather than basic preventative strategies and alternative medicine modalities. Opponents are gravely concerned about what they see as the skyrocketing use of primitive chemical mind control techniques upon citizens, little different from chemical straitjacketing, which are solely based upon an unproven chemical imbalance theory. Uninformed consent and the incremental evisceration of civil rights, exemplified by legislation allowing outpatient commitment in 42 States now, have contributed to the heightening of their ill will toward the New Freedom Commission.

[edit]

 

Funds approved for screening

The New Freedom mental health screening initiative has received funding from both House and Senate appropriators in the 2005 federal budget. This funding allows States to create or expand mental health screening programs.

[edit]

 

See also

[edit]

 

Official US government links

[edit]

 

References

  • PsychRights.org (pdf) - Bush Plans To Screen Whole US Population for Mental Illness', Jeanne Lenzer, British Medical Journal, Vol 328, pp1458, June 19, 2004
  • PsychRights.org (pdf) - 'Secret US report surfaces on antidepressants in children', Jeanne Lenzer, British Medical Journal, Vol 329, p 307 August 7, 2004
  • PsychRights.org (pdf) - Untitled TMAP Critique, Allen Jones (January 20, 2004)



External links




Learn More About the Biopharmaceutical Industry and Clinical Research:


Category:

Logo sidebar
  • Analytical Chemistry
  • Bioinformatics
  • Biology
  • Biochemistry
  • Biotechnology
  • Biotechnology Companies
  • Cell Imaging
  • Chemistry
  • Chemists
  • Crystallography
  • Ecology
  • Environmentalism
  • Genetic Engineering
  • Genetically Modified Organisms
  • Genetics
  • Health
  • Health Care
  • Health Sciences
  • Medical Specialities
  • Medicine
  • Molecular Genetics
  • Pharmaceutical Industry
  • Pharmacy
  • Pharmacology

  • Powered by Wikipedia, the free encyclopedia. Articles were developed by IBPA volunteers.

    Logo sidebar

    A

    B

    C

    D

    E

    F

    G

    I

    K

    L

    M

    N

    P

    Q

    R

    S

    T


    Logo sidebar


    IBPA Sponsors and Active Supporters

    http://www.payoneer.com/
    Access Clinical Trials

    Access Clinical Trials
    Access Clinical Trials


    Allied Research International
    Allied Research International

    Altaspera Global Services Inc.
    Altaspera Global Services

    Financial Planning and Personal Insurance
    For Canadian Pharmaceutical Industry Executives


    Biorole Scientific Solutions
    Biorole Scientific Solutions

    CEREPROTEC INC. Development of Novel Neuroprotective Drugs
    CEREPROTEC INC. Development of Novel Neuroprotective Drugs

    Recruitment Advertising Agencies
    Recruitment Advertising Agencies

    Cellular Technology Ltd.
    Cellular Technology Ltd.

    Clinical Trial Network
    Free Database of Clinical Investigators

    ClinQua Clinical Trials Inc.
    ClinQua Clinical Trials Inc.

    Coronis Clinical Research Organization
    Coronis Clinical Research Organization

    CPIC Latin America
    CPIC Latin America

    Espoir Bridge Recruiters
    Espoir Bridge Recruiters

    Genentech
    Genentech

    ILS SA
    Independent Research and Laboratory Solutions

    Inova Health Research
    Inova Health Research, Inc.

    Kriger Research Group International
    Kriger Research Group International

    LCCT
    LCCT

    Metrics Research
    Complete Research Solutions on a Single Platform

    Pharmalef Developments
    Pharmalef Developments

    PrimeHealth Clinical Research Organization
    PrimeHealth Clinical Research Organization

    Research & Development RA SA
    Research & Development RA SA

    Scios Inc.
    Scios Inc. - Manufacturer of Health Care Products

    Scios Inc.
    Southeast Regional Research Group LLC.

    UniMR
    UniMR Clinical Research

    YM BioSciences
    YM BioSciences

    Become IBPA Sponsor
    Post Your Logo Here

    ©2004 International Biopharmaceutical Association Inc., all rights reserved
    Privacy Policy - Terms of Use

    Google